Francis Duhay

All filings by Francis Duhay on record concern enVVeno Medical Corp, in the capacity of board member. We count 9 filings; the first trade dates from 27 November 2018 and the latest from 11 September 2026.

In open-market terms, that means 3 purchases worth €329k on one side and 4 sales worth €6,450 on the other. Taken together, the purchases exceed the sales by €322k. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. The rest of the record consists of 2 share grants. In 2026 alone, the filings show no purchases and 2 sales.

A typical purchase (the median) is worth €47k. On 2 out of 3 purchases, another insider of the same company was buying within the same 30 days. Purchases made close together by different insiders form what is called a cluster. For 3 purchases whose 90-day window has closed, the share price was higher on day 90 than the day after publication in 33% of cases, with a median move of -5.1%. This is a record of the past, not a forecast.

Most recently, on 14 September 2026, the filings show an open-market sale worth €106 in enVVeno Medical Corp. The latest purchase dates back some time: it was published 675 days ago, on 3 January 2025. The median gap between a trade and its publication by SEC (Form 4) is 2 days. US insiders must file a Form 4 within two business days of a trade. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.